NCT03938428

Brief Summary

This study seeks to understand how patients feel about their medicines before and after receiving a clinical medication review.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
132

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 2, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 6, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

July 24, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
Last Updated

August 12, 2019

Status Verified

August 1, 2019

Enrollment Period

11 months

First QC Date

May 2, 2019

Last Update Submit

August 7, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients who express a change in emotion relating to how they feel about their medicines, following a pharmacist-led clinical medication review.

    1 month

Secondary Outcomes (1)

  • Patient expressed emotion

    1 month

Interventions

SurveyOTHER

Patients who are eligible for this study will have been previously identified as part of the PREFACES project. The pharmacist who has conducted the clinical medication review will obtain verbal permission from the patient to be contacted by the research study team. This will be documented on the referral outcome document that is returned to the YAS clinical team. A member of YAS clinical staff from the PREFACES project will forward the name and residential address of patients who have agreed to be contacted to the research paramedic for this study. A covering letter, participant information sheet, questionnaire and consent form, will be posted to potential participants. A stamped addressed envelope will be included to enable return of the completed booklet at no costs to participants.

Eligibility Criteria

Age18 Years - 110 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study will be conducted from a single site (Yorkshire Ambulance Service NHS Trust). YAS staff make around 70-100 falls referral pathways a month in the Leeds area, and after exclusions relating to the PREFACS projects, it is anticipated that around 55 patients per month will be eligible to receive a pharmacist-led clinical medication review and will therefore be eligible for this study, up to a maximum of 550 patients.

You may qualify if:

  • Received a pharmacist-led clinical medication review following a falls referral made by a paramedic from Yorkshire Ambulance
  • Registered with a GP in the Leeds area
  • Has capacity to consent to take part in the study

You may not qualify if:

  • Did not receive a pharmacist-led clinical medication review after a Yorkshire Ambulance Service paramedic made a falls referral
  • Not registered with a GP in the Leeds area
  • Does not have capacity to consent to take part in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yorkshire Ambulance Service NHS Trust

Wakefield, West Yorkshire, WF2 0XQ, United Kingdom

RECRUITING

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2019

First Posted

May 6, 2019

Study Start

July 24, 2019

Primary Completion

June 30, 2020

Study Completion

June 30, 2020

Last Updated

August 12, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

Locations